Presentation TCT 2023 We Need an RCT, and Here Is How I Would Like to Design It Presenter: David Cohen October 24, 2023
Presentation TCT 2023 Importance of Patient Reported Outcomes Presenter: David Cohen October 24, 2023
News Conference News TCT 2023 Some Surprises in Low-Risk TAVI Follow-up: PARTNER 3 and Evolut Trials Michael O'Riordan October 24, 2023
Presentation TCT 2023 There Are Reasons to Be Cautious – Look Beyond the Anatomy! Presenter: David Cohen October 23, 2023
News Conference News TCT 2022 Pascal TEER Device Performs Well in Patients With Complex Anatomy Yael L. Maxwell September 26, 2022
News Conference News TCT 2022 FAVOR III China: Early Gains of QFR in PCI Persist to 2 Years L.A. McKeown September 20, 2022
Presentation TCT 2022 Current Medical Therapy Is the Gold Standard for Plaque Stabilization Presenter: David J. Cohen September 18, 2022
News Conference News TCT 2022 Sizing Mismatch a Problem for Balloon-Expandable Valves in Small Annuli TAVI Yael L. Maxwell September 18, 2022
News Conference News TCT 2022 Both Surgical, Percutaneous Closure Boost Survival in Post-STEMI VSD Shelley Wood September 18, 2022
Presentation TCT 2022 Clinical Benchmarks for Therapy Success in Transcatheter Tricuspid Therapy Presenter: David Cohen September 17, 2022
Presentation TCT 2022 None Use: The Data Are Unconvincing and the Cost Is Prohibitive Presenter: David J. Cohen September 17, 2022
News Conference News TCT 2022 Pascal TEER Device as Good as MitraClip in Head-to-Head CLASP IID Michael O'Riordan September 17, 2022
News Conference News TCT 2022 New Faces, New Formats, New Tech: What to Expect From TCT 2022 Shelley Wood September 07, 2022
News Conference News TCT 2021 Debating ISCHEMIA: Do the Results Apply to CABG, Too? Michael O'Riordan November 10, 2021
Presentation TCT 2021 Evidence gaps: What’s Needed in the New Guidelines? Presenter: David Cohen November 05, 2021
Presentation TCT 2021 PARTNER 3: Two-Year Economic Outcomes From a Randomized Trial of TAVR vs. SAVR in Patients at Low Surgical Risk Presenter: David Cohen November 05, 2021
News Conference News TCT 2021 TAVI Edges Out Surgery in 2-Year Costs for Low-risk Patients: PARTNER 3 Yael L. Maxwell November 05, 2021
Presentation TCT 2021 Recognizing the Value Proposition of DCB in the Real-World Presenter: David Cohen November 04, 2021
News Conference News TCT 2020 Acurate Neo Still Falls Short of Sapien 3 in SCOPE 1-Year Follow-up Michael O'Riordan October 23, 2020
News Conference News TCT 2020 MitraBridge: Could a MitraClip Help Patients Avoid Heart Transplant? Shelley Wood October 16, 2020